P602. Health-related quality of life improves during 1-year of postoperative prophylactic drug therapy after ileocecal intestinal resection in Crohn’s disease patients: results of the APPRECIA randomised trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.